These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26481748)

  • 1. Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review.
    Miao XY; Ji XB; Lu HW; Yang JW; Xu JF
    Chin Med J (Engl); 2015 Oct; 128(20):2792-7. PubMed ID: 26481748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
    Blau H; Linnane B; Carzino R; Tannenbaum EL; Skoric B; Robinson PJ; Robertson C; Ranganathan SC
    J Cyst Fibros; 2014 Jan; 13(1):106-10. PubMed ID: 23806622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis.
    Kapur N; Grimwood K; Masters IB; Morris PS; Chang AB
    Pediatr Pulmonol; 2012 Mar; 47(3):300-7. PubMed ID: 21901858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARĪ³ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa.
    Burr LD; Rogers GB; Chen AC; Taylor SL; Bowler SD; Keating RL; Martin ML; Hasnain SZ; McGuckin MA
    PLoS One; 2018; 13(8):e0202296. PubMed ID: 30114278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
    Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ
    Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic characteristics of sputum and bronchoalveolar lavage fluid samples from patients with lower respiratory tract infection in a large teaching hospital in China: a retrospective study.
    Peng Z; Zhou J; Tian L
    BMC Pulm Med; 2020 Aug; 20(1):233. PubMed ID: 32867740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bronchoscopy and bronchoalveolar lavage findings in three types of suppurative lung disease.
    de Vries JJV; Chang AB; Marchant JM
    Pediatr Pulmonol; 2018 Apr; 53(4):467-474. PubMed ID: 29405664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
    McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A
    Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of bronchoalveolar lavage semiquantitative cultures in cystic fibrosis.
    Baughman RP; Keeton DA; Perez C; Wilmott RW
    Am J Respir Crit Care Med; 1997 Jul; 156(1):286-91. PubMed ID: 9230762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
    van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
    FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis.
    Ho PL; Chan KN; Ip MS; Lam WK; Ho CS; Yuen KY; Tsang KW
    Chest; 1998 Dec; 114(6):1594-8. PubMed ID: 9872194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients.
    Luo RG; Miao XY; Luo LL; Mao B; Yu FY; Xu JF
    Clin Microbiol Infect; 2019 May; 25(5):601-606. PubMed ID: 30036669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients.
    Dimakou K; Triantafillidou C; Toumbis M; Tsikritsaki K; Malagari K; Bakakos P
    Respir Med; 2016 Jul; 116():1-7. PubMed ID: 27296814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation.
    Chen AC; Martin ML; Lourie R; Rogers GB; Burr LD; Hasnain SZ; Bowler SD; McGuckin MA; Serisier DJ
    PLoS One; 2015; 10(3):e0119325. PubMed ID: 25822228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreted mucins and airway bacterial colonization in non-CF bronchiectasis.
    Sibila O; Suarez-Cuartin G; Rodrigo-Troyano A; Fardon TC; Finch S; Mateus EF; Garcia-Bellmunt L; Castillo D; Vidal S; Sanchez-Reus F; Restrepo MI; Chalmers JD
    Respirology; 2015 Oct; 20(7):1082-8. PubMed ID: 26172851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
    Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
    Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.
    Wilson CB; Jones PW; O'Leary CJ; Hansell DM; Cole PJ; Wilson R
    Eur Respir J; 1997 Aug; 10(8):1754-60. PubMed ID: 9272915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Emerging bacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis from a microbiologist's perspective].
    Menetrey Q; Dupont C; Chiron R; Marchandin H
    Rev Mal Respir; 2020 Sep; 37(7):561-571. PubMed ID: 32684338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.